Peter Greenleaf
2015 - Sucampo Pharmaceuticals
In 2015, Peter Greenleaf earned a total compensation of $3.2M as Chief Executive Officer and Chairman of the Board of Directors at Sucampo Pharmaceuticals, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $592,379 |
|---|---|
| Option Awards | $1,985,865 |
| Salary | $565,288 |
| Other | $8,843 |
| Total | $3,152,375 |
Greenleaf received $2M in option awards, accounting for 63% of the total pay in 2015.
Greenleaf also received $592.4K in non-equity incentive plan, $565.3K in salary and $8.8K in other compensation.
Rankings
In 2015, Peter Greenleaf's compensation ranked 2,992nd out of 13,638 executives tracked by ExecPay. In other words, Greenleaf earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,992 out of 13,638 | 78th |
Division Manufacturing | 1,057 out of 5,187 | 80th |
Major group Chemicals And Allied Products | 388 out of 1,857 | 79th |
Industry group Drugs | 303 out of 1,531 | 80th |
Industry Pharmaceutical Preparations | 240 out of 1,179 | 80th |
Source: SEC filing on April 21, 2017.
Greenleaf's colleagues
We found six more compensation records of executives who worked with Peter Greenleaf at Sucampo Pharmaceuticals in 2015.
2015
Andrew Smith
Sucampo Pharmaceuticals
Chief Financial Officer
2015
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2015
Thomas Knapp
Sucampo Pharmaceuticals
Chief Legal Officer
2015
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2015
Peter Lichtlen
Sucampo Pharmaceuticals
Chief Medical Officer
2015
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019